NFKB1 and inflammatory bowel disease: Animal and human studies have revealed that the role of the NLRP3 inflammasome in the pathogenesis of IBD remains unclear (Thomas et al., 2022); in this study, we found that hyperactivation of intestinal NF-κB and NLRP3 aggravated experimental colitis in mice.